Starling Oncology STLN
NASDAQ STLN
$5.97 -0.12 (-1.97%)
At close: Sep 3, 2026 · 4:00 PM EDT

Starling Oncology (STLN) EBT Margin Growth (1y) (2022 - 2026)

Analysis

Starling Oncology (STLN) EBT Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 HCA Healthcare 90.36 Bn 89.35 Bn 15.19 Bn -65.00
2 Tenet Healthcare 22.02 Bn 19.85 Bn 4.45 Bn 1,163.00
3 Encompass Health 12.13 Bn 11.99 Bn 1.34 Bn 13.00
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn 132.00
5 Universal Health Services 10.09 Bn 9.95 Bn 3.29 Bn -72.00
6 Ensign 9.97 Bn 9.65 Bn 306.24 Mn 13.00
7 Chemed 6.93 Bn 6.89 Bn 221.47 Mn 207.00
8 Pacs 6.81 Bn 6.64 Bn 338.46 Mn 141.00
9 Concentra Group Holdings Parent 4.32 Bn 4.16 Bn 192.10 Mn 360.00
10 Starling Oncology 609.95 Mn 568.85 Mn 27.17 Mn 824.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 824.00
Mar 31, 2026 1,707.00
Dec 31, 2025 786.00
Sep 30, 2025 404.00
Jun 30, 2025 140.00
Mar 31, 2025 225.00
Dec 31, 2024 908.00
Sep 30, 2024 494.00
Jun 30, 2024 524.00
Mar 31, 2024 1,830.00
Dec 31, 2023 -630.00
Sep 30, 2023 -1,692.00
Jun 30, 2023 -1,194.00
Mar 31, 2023 -7,460.00
Dec 31, 2022 821.00
Sep 30, 2022 2.00
Jun 30, 2022 -1,700.00
Mar 31, 2022 3,689.00